share_log

健康元(600380.SH):1类流感新药TG-1000已启动Ⅲ期临床试验,目前入组进度已过半

Health Source (600380.SH): TG-1000, a new class 1 influenza drug, has begun phase III clinical trials. Currently, the enrollment process is over half

Gelonghui Finance ·  Dec 27, 2023 03:00

Gelonghui, December 27丨Health Yuan (600380.SH) said on an interactive platform that the company's new class 1 influenza drug, TG-1000, has begun phase III clinical trials. Since autumn and winter are high influenza seasons, the enrollment process is now over half. We will proceed with clinical trials and subsequent marketing as soon as possible. If there is any relevant progress, the company will promptly fulfill its information disclosure obligations in accordance with relevant regulations.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment